COLETTE : Study of the Pathophysiology of Status Epilepticus and Dysimmune Encephalitis and Identification of Valuable Biomarkers
COLETTE is an interventional study for which blood, cerebrospinal fluid and post-mortem tissues are collected in patients with status epilepticus or epilepsy associated to dysimmune encephalitis as well as in control patients, to better understand the pathophysiology of these severe epileptic disorders.
⁃ Group 1:
• Patients aged 2 years or above, with status epilepticus.
• Affiliation to a French social security system excluding Aide Médicale Etat (AME).
• Patients or relatives have been informed and given free informed and written consent to participate
• Patients under legal protection (guardianship, curatorship) or not
⁃ Group 2:
• Patients aged 2 years or above, with clinical signs of epilepsy associated to dysimmune encephalitis.
• Affiliation to a French social security system excluding Aide Médicale Etat (AME).
• Patients or relatives have been informed and given free informed and written consent to participate
• Patients under legal protection (guardianship, curatorship) or not
⁃ Group 3:
• Patients aged 18 years or above, without status epilepticus and/or dysimmune encephalitis.
• Affiliation to a French social security system excluding Aide Médicale Etat (AME).
• Patients or relatives have been informed and given free informed and written consent to participate
• Patients under legal protection (guardianship, curatorship) or not